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Syzygium cumini L. better known as Jamun belonging to the family Myrtaceae is identified to have antidiabetic,
anti-inflammatory, anti-pyretic and anti-oxidant activities. Anticancer activity of S. cumini L. fruits has been
demonstrated. However, anticancer activity of S. cumini seeds on various types of human cancers has not been
explored much. The methanol fraction of ethanol extract from the seeds of S. cumini was found to have significant
antibacterial activity. This bioactive fraction was further tested positive for its anticancer activity on various types
of human cancer cell lines indicating its potency. Structural characterization of the bioactive fraction was
achieved using analysis of high performance liquid chromatography, ultra violet and infra red spectrum.
Key words: Syzygium cumini L., antibacterial activity, cytotoxic activity, structural characterization
___________________________________________________________________________
_________________
∗Corresponding author. Phone: +91-9869244226
E-mail: madhavupadhye@gmail.com
INTRODUCTION
The Myrtaceae is a large family of plants consisting
of trees and shrubs found in the tropics and subtropics
and comprises about 150 genera and 3,600 species
(Cronquist 1981). Syzygium cumini L. better known as
Jamun is an important member of this family widely
distributed all over the Indian sub-continent (British Herbal
Pharmacopeia 1976). The fruits and seeds of S. cumini are
used to treat diabetes mellitus for several centuries in
folklore medicine of south Asia. The seeds are used as
astringent and diuretic (Bhatia & Bajaj 2005). They have
hypoglycaemic (Chopra et al. 1958; Mahapatra et al. 1985;
Stanely et al. 1998a), anti-inflammatory (Chaudhary et al.
1990), antipyretic (Ghosh et al. 1985), psychopharmacological
(Chakraborty et al. 1985), hypolipidaemic (Stanely &
Menon 1997), and antioxidant (Stanely & Menon 1998b;
Banerjee et al. 2005; Benherlal & Arumughan 2007; Bushra
et al. 2007) activities. Craveiro et al. (1983), studied the
essential oils of leaves, stems, and fruits of S. cumini and
their antibacterial activity was reported by Shafi et al.
(2002).
Cancer is a public health problem worldwide.
According to WHO, 20 million people in the world suffer
from cancer, a figure projected to rise to 30 million within
20 years (WHO 2004). The search for anticancer agents
from plants dates back to 1947, when the cytotoxic
properties of podophyllotoxin from Podophyllum
peltatum (Berberidaceae) were detected (Kelly & Hartwell
1954). The discovery of the antileukemic properties of
vinblastine and vincristine from Cataranthus roseus
(Apocynaceae) soon followed (Noble et al. 1958) and gave
the impulse for wider ranging investigations of plant
extracts and plant-derived compounds for possible
anticancer activity. In the case of human cancers, thus far,
nine plant-derived compounds have been approved for
clinical use in the United States. They are vinblastine,
vincristine, the campothecin derivatives-topotecan and
irinotecan, etoposide and paclitaxel. A number of promising
agents such as roscovitine, betulinic acid and silvestrol
are in clinical or preclinical development (Shoeb 2006).
Few reports have indicated potential of S. cumini fruits
to combat cancer. Nazif (2007) isolated four anthocyanins
from acidic alcoholic extract of S. cumini fruits in Egypt
and the crude extract was found to exhibit potent cytotoxic
activity on several types of human cancer cell lines. Barh
and Viswanathan (2008) showed that the crude extract of
S. cumini fruits inhibited growth and induced apoptosis
in cervical cancer cell lines HeLa and SiHa in a dose and
time-dependent manner. There is no report available on
anticancer activity of extracts of S. cumini seeds. So the
present study was undertaken to isolate, characterize a
bioactive fraction from S. cumini seeds and evaluate its
anticancer activity on human cancer cell lines in vitro.
MATERIALS  AND  METHODS
Collection of Plant Material. Syzygium cumini L.
(Jamun) fruits were collected fresh from Keshav Shristi,
Bhayandar, brought to the laboratory and washed with
distilled water. The plant was identified and authenticated
at the Blatter Herbarium St. Xavier’s College, Mumbai-400
001, India, with specimen no. 1848 of G. L. Shah. The outer
covering of the fruit was removed; seed was taken and
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dried in oven at a constant temperature. The dried seeds
were ground in electrical mill and the powdered seeds
were kept separately in plastic containers in dark until
used.
Preparation of Ethanolic Seed Extract of Syzygium
cumini L. A suspension of 800 g of seed powder in 1,000 ml
of ethanol was stirred manually for half an hour and the
resultant mixture was kept in the refrigerator at 4 oC
overnight. The suspension was then centrifuged for 5
minutes at 6,000 rpm. The supernatant was concentrated
in a rotary evaporator. The process was repeated for seven
days to get 20 g ethanol extract.
This resultant alcoholic extract obtained was subjected
to solvent extraction method using petroleum ether,
chloroform and ethyl acetate. The ethyl acetate fraction
was found to be bioactive using bioassay and thus
selected for further studies. This bioactive fraction was
subjected to column chromatography to obtain a
methanolic fraction which was further purified using
preparative thin layer chromatography using solvent
system chloroform:ethyl acetate:methanol (30:50:20) to
isolate a single compound.
Evaluation of Antibacterial Activity (Bioassay). The
isolated compound was tested against four
microorganisms by agar cup method (Spooner & Skyes
1972). Bioassay was done using agar cup method using
two gram positive and two negative test organisms. Agar
wells were made using sterile cork borer of diameter 8 mm.
All bioassays were carried out in triplicate and average
values were taken.
Evaluation of Anticancer Activity Cell lines and
Culture Maintenance Conditions. CellTiter96® AQueous
non-radioactive MTS reagent was purchased from
Promega Co. (WI, USA). Fetal bovine serum (FBS) was
from Hyclone (Logan, UT, USA).  All other chemicals and
media were purchased from Sigma. The human cancer cell
lines MCF7 (breast adenocarcinoma), A2780 (ovarian
adenocarcinoma), PC-3 (prostate carcinoma), H460 (non-
small cell lung carcinoma) were purchased from American
Type Culture Collection (MD, USA). All the cell lines were
grown in RPMI-1640 culture medium, supplemented with
10% heat inactivated FBS, 2% L-glutamine (200 mmol/l)
and 1% penicillin-streptomycin. Cells were grown as a
monolayer culture in T-75 flasks at 37 oC in a humidified
5% CO2 incubator.
In Vitro Cytotoxicity Assay. When 80% confluence
was reached in T-75 flasks, cells were harvested with
0.025% trypsin/EDTA, washed with PBS and counted
using trypan blue dye exclusion method. Each cell line
was seeded into 96-well flat bottom microtiter plates at a
density of 3,000 cells/well and left to attach to the plates
for 24 h. Next day, 20 μl of culture medium or medium
containing the test compound was added to the wells.
Each concentration was plated in triplicate. The isolated
compound from the seeds of S. cumini L. was dissolved
in dimethylsulfoxide (DMSO) and applied in five
concentrations (300, 100, 30, 10, 3 μg/ml). Flavopiridol
(positive control) was applied in four concentrations (1,
0.3, 0.1, and 0.03 μmol/l). Following 48 h of drug exposure,
the effect on the cell viability was measured using MTS
cell proliferation assay (Cory et al. 1991). 20 μl of
CellTiter96® Aqueous non-radioactive MTS reagent was
added to each well. Cells were incubated further to allow
for color development before the absorbance values were
read at 490 nm using a microplate reader. A blank control
was included by mixing media and MTS reagent absence
of cells. The highest DMSO concentration was 0.5%. At
this concentration, DMSO did not alter cell viability (data
not shown).
Structural Characterization. Structural Characterization
of the bioactive fraction was done with the help of UV
spectrophotometer (Pharma Spec by Schimadzu) to find
out the wavelength of maximum absorption. It was
followed by HPLC analysis (Model No. 1100 by Agilent
with binary pump and VWD detector) to check the purity
of the isolated fraction. Then an FTIR spectrum (Perkin
Elmer) was studied to find out the functional groups
present in the isolated fraction. Melting point was also
recorded by capillary method.
RESULTS
Purified methanol fraction from ethanol extract of the
seed of S. cumini L. exhibited significant antibacterial
activity against all the test microorganisms (Table 1).
Highest zone of inhibition of 20 mm was observed against
E. coli while Pseudomonas aeruginosa was found to be
moderately sensitive as it indicated an inhibition zone of
11 mm. Overall the isolated compound was found to be
active against both gram positive as well as gram negative
organisms suggesting its broad range of antibacterial
activity.
The cytotoxic activity of the seed extract of S. cumini
L. on various cancer cell lines was examined by MTS assay.
The results of the cytotoxicity evaluation exposure time
48 h are summarized in Table 2. Growth stimulation/
inhibition was calculated as treated/control × 100 (%T/C).
Cytotoxicity curves (Figure 1) were obtained by plotting
percentage of viability against different concentrations
of the extract. All results were expressed as IC50 values,
the concentration of the extract that inhibited cell
proliferation up to 50% of the negative control. A2780
Table 1. Antibacterial activity of isolated compound from S. cumini
L. seeds
Test organism          E. coli   P. aeruginosa   S. aureus   B. subtilis
Zone of
inhibition (mm)
20 11 17 15
Table 2. Mean IC50 values of isolated compound from S. cumini L.
seeds in human cancer cell lines
                                                    Mean IC50 (μg/ml)
                               S. cumini seed extract               FlavopiridolCell line
A2780
MCF7
PC-3
H460
49
110
140
165
0.06
0.06
0.08
0.07
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(ovarian cancer) cell line was found to be most sensitive
with IC50 value of 49 μg/ml while H460 (non small cell lung
carcinoma) was least sensitive (IC50 value of 165 μg/ml).
Flavopiridol (positive control) showed very low IC50 values
(0.06-0.08 μg/ml) on all the cell lines.
Ultra violet spectrum (Figure 2) showed a peak at 217
nm indicating presence of C=C double bond while a peak
at 270 nm indicated presence of carbonyl (>C=O) group
along with conjugation. HPLC analysis confirmed the
purity of isolated compound whose percentage area was
found to be 96.67% and peak height of 10143.55 μAU
having a retention time of 17.441 mins (Figure 3). FTIR
spectrum (Figure 4) showed peaks at 3367 cm-1 and 3288 cm-1
indicating the presence of  –OH (hydroxyl) group whereas
a peak at 1702 cm-1  indicated presence of >C=O (carbonyl)
group, three peaks at 1617, 1541,  and 1449 cm-1  indicated
presence of aromatic C-C stretching while peak at 1339 cm-1
suggested presence of aliphatic C-H stretching. Finally
peaks at 1245 and 1025 cm-1 indicated presence of aliphatic
C-C stretching in the bioactive fraction. Melting point
was found to be above 250 oC.
DISCUSSION
Bioassay studies clearly indicated that the purified
methanol fraction has antibacterial activity against both
gram positive as well as negative bacteria and therefore in
future, it could be further purified and explored for
producing antibacterial substances from this easily
available and widely distributed cheaper plant. This could
be a reason of usage of S. cumini seeds in traditional
Ayurvedic and Homeopathic medicines. Earlier, Karthic
et al. (2008) showed that aqueous extract of S. cumini
seeds showed inhibition against porcine pancreatic α-
amylase.  Constituents of S. cumini seeds were found out
to be fatty oils, tannins which include ellagic acid,
ellagitannins, gallic acid, corilagen, phenolic componets
such as ferulic acid, quercetin, veratrole, caffeic acid
(EMEA 1999). Among these, ferulic, caffeic, gallic acids
were tested for their potential anti proliferative and
cytotoxic properties in human breast cancer cell line
(MCF-7) as well as on a spontaneous mammary
adenocarcinoma tumor. As a single agent, caffeic acid
showed substantial growth inhibitory activity (Indap et
al. 2008). Caffeic acid and its derivatives have been shown
to be effective against HL-60 (human leukemia) cells (Chen
et al. 1996). Flavonoid quercetin has been demonstrated
to possess anticancer activity against different types of
cancer cells (El Attar & Virji 1999; Aalinkeel et al. 2008;
Zamin et al. 2009; Du et al. 2009; Shan et al. 2009; Zhang
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Figure 1. Growth inhibitory effect of isolated compound from S.
cumini L. seeds on various cancer cell line.
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Figure 2. UV spectrum of isolated compound from S. cumini L.
seeds.
& Zhang 2009). Ellagic acid has been demonstrated to
have anticancer activity against several types of cancer
such as skin, pancreas, colon and esophegal cancer
(Edderkaoui et al. 2008). Thus, the anticancer activity of
S. cumini L. seed extract could be attributed to these
constituents. This is the first ever report of its kind which
reports cytotoxic activity of bioactive extracts prepared
from seeds of S. cumini L. which are considered to be a
waste – useless product and often discarded after
consuming the fruit pulp. More studies are therefore
warranted to isolate and characterize such bioactive
fractions from this plant.
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